Diagnosis and Minimal Invasive Treatment of Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a common condition in men aged 50-60 years with a prevalence of about 50 %. After failure of conservative treatment, the standard treatment of BPH is transurethral resection of the prostate (TURP). However, over the last years prostatic artery embotization (PAE) emerged as a minimal invasive alternative to treat tower urinary tract symptoms. After patient assessment by MRI and CT of the prostate to rule out possible contraindications of PAE, the procedure can be performed in an outpatient setting under local anesthesia by an interventional radiologist. Especially for frail patients and /or patients with special risks regarding surgery/anesthesia, PAE may be an alternative to TURP with fewer complications.